Published in J Neurosci Methods on June 15, 2007
Predictive animal models of mania: hits, misses and future directions. Br J Pharmacol (2011) 1.04
Sweet success, bitter defeat: a taste phenotype predicts social status in selectively bred rats. PLoS One (2012) 0.80
Animal models of bipolar mania: The past, present and future. Neuroscience (2015) 0.78
Synapsin IIb as a functional marker of submissive behavior. Sci Rep (2015) 0.75
Exploring diazepam's effect on hemodynamic responses of mouse brain tissue by optical spectroscopic imaging. Biomed Opt Express (2014) 0.75
Testing the social competition hypothesis of depression using a simple economic game. BJPsych Open (2016) 0.75
Modeling mania in preclinical settings: A comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry (2015) 0.75
Activity-dependent neuroprotective protein: a novel gene essential for brain formation. Brain Res Dev Brain Res (2003) 1.38
Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model. J Pharmacol Exp Ther (2007) 1.30
Differential effects of ethanol antagonism and neuroprotection in peptide fragment NAPVSIPQ prevention of ethanol-induced developmental toxicity. Proc Natl Acad Sci U S A (2003) 1.23
NAP, a femtomolar-acting peptide, protects the brain against ischemic injury by reducing apoptotic death. Stroke (2002) 1.01
Novel peptides prevent alcohol-induced spatial learning deficits and proinflammatory cytokine release in a mouse model of fetal alcohol syndrome. Am J Obstet Gynecol (2005) 1.00
2-Amino-3,4-dihydroquinazolines as inhibitors of BACE-1 (beta-site APP cleaving enzyme): Use of structure based design to convert a micromolar hit into a nanomolar lead. J Med Chem (2007) 0.97
Protective peptides that are orally active and mechanistically nonchiral. J Pharmacol Exp Ther (2004) 0.97
Subcellular localization and secretion of activity-dependent neuroprotective protein in astrocytes. Neuron Glia Biol (2004) 0.96
Activity-dependent neurotrophic factor-9 and NAP promote neurite outgrowth in rat hippocampal and cortical cultures. J Mol Neurosci (2005) 0.95
Programmed acute electrical stimulation of ventral tegmental area alleviates depressive-like behavior. Neuropsychopharmacology (2008) 0.94
NAP and ADNF-9 protect normal and Down's syndrome cortical neurons from oxidative damage and apoptosis. Curr Pharm Des (2007) 0.92
Cathepsins B and L differentially regulate amyloid precursor protein processing. J Pharmacol Exp Ther (2008) 0.92
Carbonic anhydrase-II inhibition. what are the true enzyme-inhibitory properties of the sulfamide cognate of topiramate? J Med Chem (2008) 0.91
From vasoactive intestinal peptide (VIP) through activity-dependent neuroprotective protein (ADNP) to NAP: a view of neuroprotection and cell division. J Mol Neurosci (2003) 0.88
Vasoactive intestinal peptide in the brain of a mouse model for Down syndrome. Exp Neurol (2003) 0.87
Carisbamate, a novel neuromodulator, inhibits voltage-gated sodium channels and action potential firing of rat hippocampal neurons. Epilepsy Res (2008) 0.87
The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide. Peptides (2003) 0.86
Learning enhancement with neuropeptides. Am J Obstet Gynecol (2006) 0.85
Neonatal mice of the Down syndrome model, Ts65Dn, exhibit upregulated VIP measures and reduced responsiveness of cortical astrocytes to VIP stimulation. J Mol Neurosci (2006) 0.85
Involvement of pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors in the mechanism of antidepressant action. J Mol Neurosci (2008) 0.84
A vasoactive intestinal peptide receptor analog alters the expression of homeobox genes. Life Sci (2002) 0.84
The expression of activity-dependent neuroprotective protein (ADNP) is regulated by brain damage and treatment of mice with the ADNP derived peptide, NAP, reduces the severity of traumatic head injury. Curr Alzheimer Res (2005) 0.82
The role of activity-dependent neuroprotective protein in a mouse model of fetal alcohol syndrome. Am J Obstet Gynecol (2003) 0.82
The pregnant spontaneously hypertensive rat as a model of asymmetric intrauterine growth retardation and neurodevelopmental delay. Hypertens Pregnancy (2005) 0.82
Antagonism of VIP-stimulated cyclic AMP formation in chick brain. J Mol Neurosci (2003) 0.81
Identification of eukaryotic elongation factor-2 as a novel cellular target of lithium and glycogen synthase kinase-3. Mol Cell Neurosci (2010) 0.81
Comparative analysis of the behavioral and biomolecular parameters of four mouse strains. J Mol Neurosci (2011) 0.81
Novel, broad-spectrum anticonvulsants containing a sulfamide group: advancement of N-((benzo[b]thien-3-yl)methyl)sulfamide (JNJ-26990990) into human clinical studies. J Med Chem (2009) 0.80
Examination of two independent kinetic assays for determining the inhibition of carbonic anhydrases I and II: structure-activity comparison of sulfamates and sulfamides. Chem Biol Drug Des (2006) 0.79
High-throughput siRNA-based functional target validation. J Biomol Screen (2004) 0.79
Incensole acetate reduces depressive-like behavior and modulates hippocampal BDNF and CRF expression of submissive animals. J Psychopharmacol (2012) 0.79
Vasoactive intestinal peptide regulation of nerve growth factor in the embryonic mouse. Peptides (2002) 0.79
Sexual dimorphism of activity-dependent neuroprotective protein in the mouse arcuate nucleus. Neurosci Lett (2005) 0.79
Selective breeding for dominant and submissive behavior in Sabra mice. J Affect Disord (2010) 0.78
Differential responses to distinct psychotropic agents of selectively bred dominant and submissive animals. Behav Brain Res (2012) 0.78
Injections of the neuroprotective peptide NAP to newborn mice attenuate head-injury-related dysfunction in adults. Neuroreport (2003) 0.78
Carbonic anhydrase inhibition. Insight into the characteristics of zonisamide, topiramate, and the sulfamide cognate of topiramate. J Enzyme Inhib Med Chem (2008) 0.78
A single administration of the peptide NAP induces long-term protective changes against the consequences of head injury: gene Atlas array analysis. J Mol Neurosci (2002) 0.78
Assessing activity onset time and efficacy for clinically effective antidepressant and antimanic drugs in animal models based on dominant-submissive relationships. Neurosci Biobehav Rev (2007) 0.78
Vasoactive intestinal peptide mRNA and immunoreactivity are decreased in fetal alcohol syndrome model. Regul Pept (2002) 0.78
Differential expression of PACAP receptors in postnatal rat brain. Neuropeptides (2010) 0.77
Gene expression analysis for high throughput screening applications. Comb Chem High Throughput Screen (2004) 0.77
Differential expression of c-fos in a mouse model of fetal alcohol syndrome. Am J Obstet Gynecol (2003) 0.77
Chronic food administration of Salvia sclarea oil reduces animals' anxious and dominant behavior. J Med Food (2013) 0.77
Blocking the postpartum mouse dam's CB1 receptors impairs maternal behavior as well as offspring development and their adult social-emotional behavior. Behav Brain Res (2011) 0.77
NAP accelerates the performance of normal rats in the water maze. J Mol Neurosci (2002) 0.77
5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide (RWJ-51204), a new nonbenzodiazepine anxiolytic. J Pharmacol Exp Ther (2002) 0.76
Novel, broad-spectrum anticonvulsants containing a sulfamide group: pharmacological properties of (S)-N-[(6-chloro-2,3-dihydrobenzo[1,4]dioxin-2-yl)methyl]sulfamide (JNJ-26489112). J Med Chem (2013) 0.76
Differential expression of embryonic and maternal activity-dependent neuroprotective protein during mouse development. Am J Obstet Gynecol (2002) 0.76
Small-molecule anticonvulsant agents with potent in vitro neuroprotection and favorable drug-like properties. J Mol Neurosci (2013) 0.75
Macrocyclic BACE inhibitors: Optimization of a micromolar hit to nanomolar leads. Bioorg Med Chem Lett (2010) 0.75
Levels of mRNA coding for alpha-, beta-, and gamma-synuclein in the brains of newborn, juvenile, and adult rats. J Mol Neurosci (2006) 0.75
The increased proliferation of cultured neuroblastoma cells treated with vasoactive intestinal peptide is enhanced by simultaneous inhibition of neutral endopeptidase. Regul Pept (2002) 0.75
Diarylacetylene piperidinyl amides as novel anxiolytics. Bioorg Med Chem Lett (2006) 0.75
The immunomodulatory tellurium compound ammonium trichloro (dioxoethylene-O,O') tellurate reduces anxiety-like behavior and corticosterone levels of submissive mice. Behav Pharmacol (2017) 0.75
α¯ Aminoisobutyric Acid Leads a Fluorescent syn-bimane LASER Probe Across the Blood-brain Barrier. Med Chem (2016) 0.75
8-(Heteroaryl)phenalkyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-ones as opioid receptor modulators. Med Chem (2005) 0.75
Diffuse near-infrared reflectance spectroscopy during heatstroke in a mouse model: pilot study. J Biomed Opt (2012) 0.75
Summer neuropeptide conference. The 3rd joint meeting of the summer neuropeptide conference (13th annual meeting) and the European Neuropeptide Club (13th annual meeting) Montauk, NY, June 8-12, 2003. Neuropeptides (2003) 0.75